Omega Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2020 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Omega Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q2 2022.
  • Omega Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2022 was $55K, a 71.1% decline year-over-year.
  • Omega Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2022 was $718K.
  • Omega Therapeutics, Inc. annual Interest Expense for 2021 was $910K, a 17.1% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 $718K $55K -$135K -71.1% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $853K $155K -$57K -26.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $910K $169K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-10
Q3 2021 $339K +$143K +73% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $190K -$4K -2.06% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $212K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q3 2020 $196K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $194K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.